<DOC>
	<DOCNO>NCT02573064</DOCNO>
	<brief_summary>The present study design study impact empirical treatment colistin empirical monotherapy combine treatment tigecycline vancomycin mortality bacteremia Multiresistant Acinetobacter Baumannii . The main objective evaluate efficacy empirical treatment colistin combine targeted therapy . The different therapeutical intervention administer follow routine clinical practice medical centre investigator assign specific intervention subject study .</brief_summary>
	<brief_title>Impact Treatment With Colistin Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin Patients Critical</brief_title>
	<detailed_description />
	<mesh_term>Acinetobacter Infections</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<criteria>Critics include patient â‰¥ 16 year monomicrobial bloodstream infection multiresistant acinetobacter baumannii carbapenems sensitive colistin accompany systemic inflammatory response syndrome , provide receive targeted treatment colistin .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>